Last reviewed · How we verify

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal — Portfolio Competitive Intelligence Brief

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Usual routine care Usual routine care marketed

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal:

Cite this brief

Drug Landscape (2026). Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/centre-integre-universitaire-de-sante-et-services-sociaux-du-nord-de-l-ile-de-mo. Accessed 2026-05-18.

Related